Sees 2025 revenue $3.1B-$3.2B, consensus $3.14B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRN:
- Notable companies reporting after market close
- BMRN Upcoming Earnings Report: What to Expect?
- Viridian Therapeutics appoints Ajer to its board of directors
- BioMarin Pharmaceutical: Hold Rating Amid Promising Trial Results and Safety Concerns
- BioMarin Pharmaceutical: Promising Growth Driven by Palynziq Success and Pipeline Opportunities